[Change in the activity of sphingomyelinase and the level of expression of nuclear oncogenes in reversible inhibition of protein synthesis by cycloheximide].
Alesenko
A V
AV
Filippova
G N
GN
D000818:Animals; D002467:Cell Nucleus / Q000201:enzymology / Q000378:metabolism; D002843:Chromatin / Q000378:metabolism; D003513:Cycloheximide / Q000633:toxicity*; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D005786:Gene Expression Regulation; D009693:Nucleic Acid Hybridization; D009857:Oncogenes; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D011500:Protein Synthesis Inhibitors; D051381:Rats; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism*; D013109:Sphingomyelins / Q000378:metabolism; D010738:Type C Phospholipases / Q000378:metabolism
D002843:Chromatin; D011500:Protein Synthesis Inhibitors; D013109:Sphingomyelins; D003513:Cycloheximide; D012321:DNA-Directed RNA Polymerases; D010727:Phosphoric Diester Hydrolases; D010738:Type C Phospholipases; D013108:Sphingomyelin Phosphodiesterase
Izmenenie aktivnosti sfingomielinazy i urovniia ékspressii iadernykh onkogenov pri obratimom ingibirovanii sinteza belkov tsiklogeksimidom.